View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB29 Publication ID: Fall 2010 
Title: ●Additions to Listing of Exempt Chemical Mixtures 
Abstract: Under this Direct Final Rule, the Drug Enforcement Administration (DEA) is updating the Table of Exempt Chemical Mixtures found in section 1310.13 of title 21 of the Code of Federal Regulations (CFR). This action is in response to DEA’s review of new applications for exemption. Having reviewed applications and relevant information, DEA finds that these 21 preparations meet the applicable exemption criteria. Therefore, these products are exempted from the application of certain provisions of the Controlled Substances Act (CSA) pursuant to 21 CFR part 1310. Pursuant to provisions of 21 CFR section 1310.13 the manufacturers of 21 chemical mixtures listed in the rule have applied for exemption pursuant to 21 CFR section 1310.13. DEA has reviewed the applications received, as well as any additional information that may have been requested. It has been determined that (1) each of these chemical mixtures is formulated in such a way that they cannot be easily used in the illicit production of a controlled substance; and (2) the listed chemical(s) contained in these chemical mixtures cannot be readily recovered. Therefore, each of these manufacturers has received a DEA letter granting exempted status on the date shown in the table in this regulation. This regulatory action merely conforms DEA regulations to the exemptions previously issued. 
Agency: Department of Justice(DOJ)  Priority: Substantive, Nonsignificant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Completed Actions 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1310   
Legal Authority: 21 USC 811   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Direct Final Rule  09/02/2010  75 FR 53876   
Comment Period End  10/04/2010    
Direct Final Rule Effective  11/01/2010    
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Mark W. Caverly
Chief, Liaison and Policy Section
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:202 307-7297
Email: dea.diversion.policy@usdoj.gov